Skip to main content
Erschienen in: European Journal of Pediatrics 4/2015

01.04.2015 | Original Article

RSV infection among children born moderately preterm in a community-based cohort

verfasst von: Rolof G. P. Gijtenbeek, Jorien M. Kerstjens, Sijmen A. Reijneveld, Eric J. Duiverman, Arend F. Bos, Elianne J. L. E. Vrijlandt

Erschienen in: European Journal of Pediatrics | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

We aimed to determine the rates of proven respiratory syncytial virus (RSV) hospitalization and disease severity among children born moderately preterm (MP, gestational age [GA] 32–36 weeks, n = 964), children born full-term (FT, GA 38–42 weeks, n = 572), and children born early preterm (EP, GA <32 weeks, n = 524). Our second aim was to identify risk factors for RSV hospitalization among MP. We extracted data from parental questionnaires and medical records, retrieved from a community-based cohort of children aged 43–49 months. The RSV hospitalization rates of MP were higher than FT (3.9 vs. 1.2 %, relative rate 3.2; 95 % confidence interval (CI) 1.4–7.1) and equal to EP (3.9 vs. 3.2 %, relative rate 1.2; 95 % CI 0.7–2.1). MP were hospitalized at an earlier age than EP. Disease severity (based on the type of treatment and hospitalization length) was equal in all groups. Risk factors for RSV hospitalization in MP were younger age and lower birth weight. In multivariable analyses, shorter GA and passive smoking independently increased the likelihood of RSV hospitalization in MP.
Conclusion: The rates of hospitalization due to proven RSV infection are higher in MP than FT and not different between MP and EP. No difference in disease severity was observed. Among MP, the rates of RSV hospitalization are higher for lower GA and when exposed to passive smoking.
Literatur
1.
Zurück zum Zitat Ambrose CS, Anderson EJ, Simoes EA, Wu X, Elhefni H, Park CL, Sifakis F, Groothuis JR (2014) Respiratory syncytial virus disease in preterm infants in the U.S. born at 32–35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J 33:576–582CrossRefPubMedCentralPubMed Ambrose CS, Anderson EJ, Simoes EA, Wu X, Elhefni H, Park CL, Sifakis F, Groothuis JR (2014) Respiratory syncytial virus disease in preterm infants in the U.S. born at 32–35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J 33:576–582CrossRefPubMedCentralPubMed
2.
Zurück zum Zitat American Academy of Pediatrics (2009) Policy statements—modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 124:1694–1701CrossRef American Academy of Pediatrics (2009) Policy statements—modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 124:1694–1701CrossRef
3.
Zurück zum Zitat Ballow M, Cates KL, Rowe JC, Goetz C, Desbonnet C (1986) Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 20:899–904CrossRefPubMed Ballow M, Cates KL, Rowe JC, Goetz C, Desbonnet C (1986) Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 20:899–904CrossRefPubMed
4.
Zurück zum Zitat Black CP (2003) Systematic review of the biology and medical management of respiratory syncytial virus infection. Resp Care 48:209–231 Black CP (2003) Systematic review of the biology and medical management of respiratory syncytial virus infection. Resp Care 48:209–231
5.
Zurück zum Zitat Blanken MO, Koffijberg H, Nibbelke EE, Rovers MM, Bont L (2013) Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study. PLoS One 8(3):e59161CrossRefPubMedCentralPubMed Blanken MO, Koffijberg H, Nibbelke EE, Rovers MM, Bont L (2013) Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study. PLoS One 8(3):e59161CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JL, Bont L (2013) Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 368:1791–1799CrossRefPubMed Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JL, Bont L (2013) Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 368:1791–1799CrossRefPubMed
7.
Zurück zum Zitat Bloemers BL, van Furth AM, Weijerman ME, Gemke RJ, Broers CJ, van den Ende K, Kimpen JL, Strengers JL, Bont LJ (2007) Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis—a prospective birth-cohort study. Pediatrics 120:e1076–e1081CrossRefPubMed Bloemers BL, van Furth AM, Weijerman ME, Gemke RJ, Broers CJ, van den Ende K, Kimpen JL, Strengers JL, Bont LJ (2007) Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis—a prospective birth-cohort study. Pediatrics 120:e1076–e1081CrossRefPubMed
8.
Zurück zum Zitat Bont L (2009) Current concepts of the pathogenesis of RSV bronchiolitis. Adv Exp Med Biol 634:31–40CrossRefPubMed Bont L (2009) Current concepts of the pathogenesis of RSV bronchiolitis. Adv Exp Med Biol 634:31–40CrossRefPubMed
9.
Zurück zum Zitat Boyce TG, Mellen BG, Mitchel EFJ, Wright PF, Griffin MR (2000) Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 137:865–870CrossRefPubMed Boyce TG, Mellen BG, Mitchel EFJ, Wright PF, Griffin MR (2000) Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 137:865–870CrossRefPubMed
10.
Zurück zum Zitat Bradley JP, Bacharier LB, Bonfiglio J, Schechtman LB, Strunk R, Storch G, Castro M (2005) Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115(1):e7–e14PubMed Bradley JP, Bacharier LB, Bonfiglio J, Schechtman LB, Strunk R, Storch G, Castro M (2005) Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115(1):e7–e14PubMed
11.
Zurück zum Zitat Carbonell-Estrany X, Simoes EA, Fullarton JR, Ferdynus C, Gouyon JB (2010) Validation of a model to predict hospitalization due to RSV of infants born at 33–35 weeks’ gestation. J Perinat Med 38(4):411–417CrossRefPubMed Carbonell-Estrany X, Simoes EA, Fullarton JR, Ferdynus C, Gouyon JB (2010) Validation of a model to predict hospitalization due to RSV of infants born at 33–35 weeks’ gestation. J Perinat Med 38(4):411–417CrossRefPubMed
12.
Zurück zum Zitat Carroll KN, Bebretsandik T, Griffin MR, Dupont WD, Mitchel EFJ, Wu P, Enriquez R, Hartert TV (2007) Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy. Pediatrics 119:1104–1112CrossRefPubMed Carroll KN, Bebretsandik T, Griffin MR, Dupont WD, Mitchel EFJ, Wu P, Enriquez R, Hartert TV (2007) Maternal asthma and maternal smoking are associated with increased risk of bronchiolitis during infancy. Pediatrics 119:1104–1112CrossRefPubMed
13.
Zurück zum Zitat Conway SP, Dear PR, Smith I (1985) Immunoglobulin profile of the preterm baby. Arc Dis Child 60:208–212CrossRef Conway SP, Dear PR, Smith I (1985) Immunoglobulin profile of the preterm baby. Arc Dis Child 60:208–212CrossRef
14.
Zurück zum Zitat Crone MR, Vogels AG, Hoekstra F, Treffers PD, Reijneveld SA (2008) A comparison of four scoring methods based on the parent-rated Strengths and Difficulties Questionnaire as used in the Dutch preventive child health care system. BMC Public Health 8:106CrossRefPubMedCentralPubMed Crone MR, Vogels AG, Hoekstra F, Treffers PD, Reijneveld SA (2008) A comparison of four scoring methods based on the parent-rated Strengths and Difficulties Questionnaire as used in the Dutch preventive child health care system. BMC Public Health 8:106CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Doering G, Gusenleitner W, Belohradsky BH, Burdach S, Resch B, Liese JG (2006) The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks’ gestational age. Pediatr Infect Dis J 25:1188–1190CrossRefPubMed Doering G, Gusenleitner W, Belohradsky BH, Burdach S, Resch B, Liese JG (2006) The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks’ gestational age. Pediatr Infect Dis J 25:1188–1190CrossRefPubMed
16.
Zurück zum Zitat Faber TE, Jimoen JL, Bont LJ (2008) Respiratory syncytial virus bronchiolitis: prevention and treatment. Expert Opin Pharmaco 9:2451–2458CrossRef Faber TE, Jimoen JL, Bont LJ (2008) Respiratory syncytial virus bronchiolitis: prevention and treatment. Expert Opin Pharmaco 9:2451–2458CrossRef
17.
Zurück zum Zitat Figueras-Aloy J, Carbonell-Estrany X, Quero J, Fernándex-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, Doménech-Martínez E (2008) FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J 27:788–793CrossRefPubMed Figueras-Aloy J, Carbonell-Estrany X, Quero J, Fernándex-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, Doménech-Martínez E (2008) FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J 27:788–793CrossRefPubMed
18.
Zurück zum Zitat Glezen WP, Taber LH, Frank AL, Kasel JA (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140(6):543–546PubMed Glezen WP, Taber LH, Frank AL, Kasel JA (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140(6):543–546PubMed
19.
Zurück zum Zitat Grimwood K, Cohet C, Rich FJ, Cheng S, Wood C, Redshaw N, Cunningham CW, Pearce N, Kirman JR (2008) Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. Epidemiol Infect 136:1333–1341CrossRefPubMedCentralPubMed Grimwood K, Cohet C, Rich FJ, Cheng S, Wood C, Redshaw N, Cunningham CW, Pearce N, Kirman JR (2008) Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. Epidemiol Infect 136:1333–1341CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329:1524–1530CrossRefPubMed Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329:1524–1530CrossRefPubMed
21.
Zurück zum Zitat Gunville CF, Sontag MK, Stratton KA, Ranade DJ, Abman SH, Mourani PM (2010) Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness. J Pediatr 157:209–214CrossRefPubMedCentralPubMed Gunville CF, Sontag MK, Stratton KA, Ranade DJ, Abman SH, Mourani PM (2010) Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness. J Pediatr 157:209–214CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Horn SD, Smout RJ (2003) Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr 143(Suppl 5):S133–S141CrossRefPubMed Horn SD, Smout RJ (2003) Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr 143(Suppl 5):S133–S141CrossRefPubMed
23.
Zurück zum Zitat Iwane MK, Edwards KM, Szilgyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B (2004) Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113:1758–1764CrossRefPubMed Iwane MK, Edwards KM, Szilgyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B (2004) Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 113:1758–1764CrossRefPubMed
24.
Zurück zum Zitat Kerstjens JM, Bos AF, Ten Vergert EM, de MG, Butcher PR, Reijneveld SA (2009) Support for the global feasibility of the Ages and Stages Questionnaire as developmental screener. Early Hum Dev 85:443–447CrossRefPubMed Kerstjens JM, Bos AF, Ten Vergert EM, de MG, Butcher PR, Reijneveld SA (2009) Support for the global feasibility of the Ages and Stages Questionnaire as developmental screener. Early Hum Dev 85:443–447CrossRefPubMed
25.
Zurück zum Zitat Kerstjens JM, de Winter AF, Bocca-Tjeertes IF, Ten Vergert EM, Reijneveld SA, Bos AF (2011) Developmental delay in moderately preterm-born children at school entry. J Pediatr 159(1):92–98CrossRefPubMed Kerstjens JM, de Winter AF, Bocca-Tjeertes IF, Ten Vergert EM, Reijneveld SA, Bos AF (2011) Developmental delay in moderately preterm-born children at school entry. J Pediatr 159(1):92–98CrossRefPubMed
26.
Zurück zum Zitat Lanari M, Adorni F, Silvestri M, Coscia A, Musicco M (2011) The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: preliminary results. Early Hum Dev 87(Suppl 1):S43–S46CrossRefPubMed Lanari M, Adorni F, Silvestri M, Coscia A, Musicco M (2011) The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: preliminary results. Early Hum Dev 87(Suppl 1):S43–S46CrossRefPubMed
27.
Zurück zum Zitat Law BJ, Langley JM, Allen U, Paes B, Lee DS, Mitchell I, Sampalis J, Walti H, Robinson J, O’Brien K, Majaesic C, Caouette G, Frenette L, Le Saux N, Simmons B, Moisiuk S, Sankaran K, Ojah C, Singh AJ, Lebel MH, Bachevie GS, Onyett H, Michaliszyn A, Manzi P, Parison D (2004) The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 23:806–814CrossRefPubMed Law BJ, Langley JM, Allen U, Paes B, Lee DS, Mitchell I, Sampalis J, Walti H, Robinson J, O’Brien K, Majaesic C, Caouette G, Frenette L, Le Saux N, Simmons B, Moisiuk S, Sankaran K, Ojah C, Singh AJ, Lebel MH, Bachevie GS, Onyett H, Michaliszyn A, Manzi P, Parison D (2004) The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 23:806–814CrossRefPubMed
28.
Zurück zum Zitat Liese JG, Grill E, Fischer B, Roeckl-Wiednann I, Carr D, Belohradsky BH (2003) Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr 162:230–236PubMed Liese JG, Grill E, Fischer B, Roeckl-Wiednann I, Carr D, Belohradsky BH (2003) Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr 162:230–236PubMed
29.
Zurück zum Zitat Madhi SA, Kuwanda L, Cutland C, Klugman KP (2006) Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children. J Clin Vir 36:215–221CrossRef Madhi SA, Kuwanda L, Cutland C, Klugman KP (2006) Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children. J Clin Vir 36:215–221CrossRef
30.
Zurück zum Zitat Meerhof TJ, Paget JW, Kimoen JL, Schellevis F (2009) Variation of respiratory syncytial virus and the relation with meteorological factors in different winter seasons. Pediatr Infect Dis J 28:860–866CrossRef Meerhof TJ, Paget JW, Kimoen JL, Schellevis F (2009) Variation of respiratory syncytial virus and the relation with meteorological factors in different winter seasons. Pediatr Infect Dis J 28:860–866CrossRef
31.
Zurück zum Zitat NVK (2005) Point of view: ‘Passive immunisation for RSV disease’. www.nvk.nl. Accessed 15 Jan 2011 NVK (2005) Point of view: ‘Passive immunisation for RSV disease’. www.​nvk.​nl. Accessed 15 Jan 2011
32.
Zurück zum Zitat Resch B, Gusenleitner W, Müller WD, Haas J (2006) Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29–32 weeks. Eur J Clin Microbiol 25:120–122CrossRef Resch B, Gusenleitner W, Müller WD, Haas J (2006) Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29–32 weeks. Eur J Clin Microbiol 25:120–122CrossRef
33.
Zurück zum Zitat Resch B, Paes B (2011) Are late preterm infants as susceptible to RSV infection as full term infants? Early Hum Dev 87(Suppl 1):S47–S49CrossRefPubMed Resch B, Paes B (2011) Are late preterm infants as susceptible to RSV infection as full term infants? Early Hum Dev 87(Suppl 1):S47–S49CrossRefPubMed
34.
Zurück zum Zitat Riccetto AG, Ribeiro JD, Silva MT, Almeida RS, Baracat EC (2006) Respiratory syncytial virus (RSV) in infants hospitalized for acute lower respiratory tract disease: incidence and associated risks. Braz J Infect Dis 10:357–361CrossRefPubMed Riccetto AG, Ribeiro JD, Silva MT, Almeida RS, Baracat EC (2006) Respiratory syncytial virus (RSV) in infants hospitalized for acute lower respiratory tract disease: incidence and associated risks. Braz J Infect Dis 10:357–361CrossRefPubMed
35.
Zurück zum Zitat Rietveld E, Vergouwe Y, Steyerberg EW, Huysman MW, de Groot R, Moll HA (2006) Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule. Pediatr Infect Dis J 25:201–207CrossRefPubMed Rietveld E, Vergouwe Y, Steyerberg EW, Huysman MW, de Groot R, Moll HA (2006) Hospitalization for respiratory syncytial virus infection in young children: development of a clinical prediction rule. Pediatr Infect Dis J 25:201–207CrossRefPubMed
36.
Zurück zum Zitat Rochat I, Leis P, Bouchardy M, Oberli C, Sourial H, Friedle-Burri M, Perneger T, Barazzone Argiroffo C (2012) Chest physiotherapy using passive expiratory techniques does not reduce bronchiolitis severity: a randomised controlled trial. Eur J Pediatr 171:457–462CrossRefPubMed Rochat I, Leis P, Bouchardy M, Oberli C, Sourial H, Friedle-Burri M, Perneger T, Barazzone Argiroffo C (2012) Chest physiotherapy using passive expiratory techniques does not reduce bronchiolitis severity: a randomised controlled trial. Eur J Pediatr 171:457–462CrossRefPubMed
37.
Zurück zum Zitat Shay DK, Holman RC, Newman RD, Liu LL, Anderson LJ (1999) Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 282:1440–1446CrossRefPubMed Shay DK, Holman RC, Newman RD, Liu LL, Anderson LJ (1999) Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 282:1440–1446CrossRefPubMed
38.
Zurück zum Zitat Shi N, Palmer L, Chu BC, Katkin JP, Hall CB, Masaquel AS, Mahadevia PJ (2011) Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants. J Med Econ 14:335–340CrossRefPubMed Shi N, Palmer L, Chu BC, Katkin JP, Hall CB, Masaquel AS, Mahadevia PJ (2011) Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants. J Med Econ 14:335–340CrossRefPubMed
40.
Zurück zum Zitat Somech R, Tal G, Gilad E, Mandelberg A, Tal A, Dalal I (2006) Epidemiologic, socioeconomic, and clinical factors associated with severity of respiratory syncytial virus infection in previously healthy infants. Clin Pediatr (Phila) 45(7):621–627CrossRef Somech R, Tal G, Gilad E, Mandelberg A, Tal A, Dalal I (2006) Epidemiologic, socioeconomic, and clinical factors associated with severity of respiratory syncytial virus infection in previously healthy infants. Clin Pediatr (Phila) 45(7):621–627CrossRef
41.
Zurück zum Zitat Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G (2012) Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006. Pediatr Infect Dis J 31:5–9CrossRefPubMed Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G (2012) Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006. Pediatr Infect Dis J 31:5–9CrossRefPubMed
42.
Zurück zum Zitat The IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531–537CrossRef The IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531–537CrossRef
43.
Zurück zum Zitat Vrijlandt EJ, Kerstjens JM, Duiverman EJ, Bos AF, Reijneveld SA (2013) Moderately preterm children have more respiratory problems during their first 5 years of life than children born full term. Am J Respir Crit Care Med 187:1234–1240CrossRefPubMed Vrijlandt EJ, Kerstjens JM, Duiverman EJ, Bos AF, Reijneveld SA (2013) Moderately preterm children have more respiratory problems during their first 5 years of life than children born full term. Am J Respir Crit Care Med 187:1234–1240CrossRefPubMed
44.
Zurück zum Zitat Welliver RC (2004) Respiratory syncytial virus infection: therapy and prevention. Paediatr Resp Rev 5(Suppl A):127–133CrossRef Welliver RC (2004) Respiratory syncytial virus infection: therapy and prevention. Paediatr Resp Rev 5(Suppl A):127–133CrossRef
Metadaten
Titel
RSV infection among children born moderately preterm in a community-based cohort
verfasst von
Rolof G. P. Gijtenbeek
Jorien M. Kerstjens
Sijmen A. Reijneveld
Eric J. Duiverman
Arend F. Bos
Elianne J. L. E. Vrijlandt
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 4/2015
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-014-2415-2

Weitere Artikel der Ausgabe 4/2015

European Journal of Pediatrics 4/2015 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.